openPR Logo
Press release

Top Pharmaceutical Drug Delivery Companies Analysis By 2031

05-12-2025 05:52 AM CET | Health & Medicine

Press release from: The Insight Partners

The Pharmaceutical Drug Delivery Market size was estimated to be US$ 1.74 billion in 2023 and is expected to reach US$ 3.15 billion by 2031; it is estimated to record a CAGR of 7.7% till 2031.

Download PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00007628?utm_source=OpenPR&utm_medium=10379

The List of Companies
• Pfizer Inc.
• Bayer AG
• Johnson & Johnson Services, Inc.
• Novartis AG
• 3M
• BD
• Sanofi
• MERCK KGaA
• GlaxoSmithKline plc.
• Antares Pharma

By Route of Administration
• Oral Drug Delivery
• Injectable Drug Delivery
• Topical Drug Delivery
• Ocular Drug Delivery
• Pulmonary Drug Delivery
• Nasal Drug Delivery
• Transmucosal Drug Delivery
• Implantable Drug Delivery

By Application
• Infectious Diseases
• Cancer
• Cardiovascular Diseases
• Diabetes
• Respiratory Diseases
• Central Nervous System Disorders
• Autoimmune Diseases

Contact US
Contact Person : Ankit Mathur
Phone : +1-646-491-9876
E-mail : sales@theinsightpartners.com

About US
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Food and Beverages, Consumers and Goods, Chemicals and Materials.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Top Pharmaceutical Drug Delivery Companies Analysis By 2031 here

News-ID: 4009263 • Views:

More Releases from The Insight Partners

Dairy Enzymes Market Growth, Trends, and Forecast by 2031
Dairy Enzymes Market Growth, Trends, and Forecast by 2031
Analyst Perspective The global dairy enzymes market is expected to register a CAGR of 6%. The market thrives due to a rise in cheese, yogurt, and dairy product consumption in developing countries. Sales are boosted by the increasing demand for processed food with dairy ingredients. Additionally, the growing awareness of lactose intolerance drives the use of dairy enzymes in low-lactose products. Soaring dairy consumption, lactose-free trend, and environmental benefits
Data Center Chip 2025: The Companies To Watch & The Critical Gaps They Must Close
Data Center Chip 2025: The Companies To Watch & The Critical Gaps They Must Clos …
Download Sample: https://www.theinsightpartners.com/sample/TIPRE00004483/?utm_source=openPR&utm_medium=10642 (Use Corporate Mail Id for Quick Response) The Data Center Chip Market is expected to register a CAGR of 13.8% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031. The report is segmented by Chip Type (Central Processing Unit (CPU), Graphics Processing Unit (GPU), Application-Specific Integrated Circuit (ASIC), Field-Programmable Gate Array (FPGA), and Others), End-user (BFSI, Healthcare, Retail,
Toasted Flour Market Key Product Segments, Application Analysis and Industry Growth Forecast by 2031
Toasted Flour Market Key Product Segments, Application Analysis and Industry Gro …
The Insight Partners has added Latest Report on Toasted Flour Market. Research Report mainly includes Size, Share, growth Factors, sales, Demand, Revenue, Trade, Forecast and Global companies Analysis. To offer more clarity regarding the industry, the report takes a closer look at the current status of various factors including but not limited to supply chain management, niche markets, distribution channel, trade, supply, and demand and production capability across different countries. Download
Transcritical CO2 Analysis and Opportunities by 2031
Transcritical CO2 Analysis and Opportunities by 2031
The transcritical CO2 market size is projected to reach US$ 156.99 billion by 2031 from US$ 54.15 billion in 2024. The market is expected to register a CAGR of 16.80% during 2025-2031. The growing need for sustainable cooling and refrigeration solutions is likely to remain a key trend in the market. To Get Sample Copy of Report, Click Here - https://www.theinsightpartners.com/sample/TIPRE00003250?utm_source=OpenPR&utm_medium=10324 Transcritical CO2 Overview The adoption of advanced technologies in refrigeration and cooling

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug